(Q36346522)

13 August 2017

1 reference

title

Role of melatonin in Alzheimer-like neurodegeneration (English)

1 reference

13 August 2017

0 references

0 references

1 reference

Jian-zhi Wang

1

1 reference

PubMed ID

16364209

13 August 2017

Ze-fen Wang

series ordinal

2

1 reference

13 August 2017

1 January 2006

1 reference

Acta Pharmacologica Sinica

13 August 2017

1 reference

13 August 2017

27

1 reference

13 August 2017

1

1 reference

13 August 2017

41-49

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2006.00260.x

13 August 2017

0 references

cites work

The human pineal gland and melatonin in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin activates PKC-alpha but not PKC-epsilon in N1E-115 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Tau aggregation into fibrillar polymers: taupathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Post-translational modifications of tau protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Effects of melatonin on wortmannin-induced tau hyperphosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Effect of melatonin on calyculin A-induced tau hyperphosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Effect of inhibiting melatonin biosynthesis on spatial memory retention and tau phosphorylation in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

The human MT1 melatonin receptor stimulates cAMP production in the human neuroblastoma cell line SH-SY5Y cells via a calcium-calmodulin signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Regulation of basal rhythmicity in protein kinase C activity by melatonin in immortalized rat suprachiasmatic nucleus cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

M<sub>1</sub> Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Divergent roles of GSK3 and CDK5 in APP processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Protective effect of melatonin on beta-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin prevents free radical formation due to the interaction between beta-amyloid peptides and metal ions [Al(III), Zn(II), Cu(II), Mn(II), Fe(II)].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

The protective effects of melatonin from oxidative damage induced by amyloid beta-peptide 25-35 in middle-aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Alzheimer's associated inflammation, potential drug targets and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

The role of inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Mechanisms of cell signaling and inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Melatonin reduces TNF-a induced expression of MAdCAM-1 via inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00260.X

10.1111/J.1745-7254.2006.00260.X

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

16364209

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16364209